IRIS PubliCatt

Rocca, Bianca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.031
NA - Nord America 3.845
AS - Asia 1.216
AF - Africa 56
SA - Sud America 56
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.810
DE - Germania 1.131
SE - Svezia 780
CN - Cina 552
UA - Ucraina 503
IT - Italia 483
IE - Irlanda 281
FR - Francia 253
SG - Singapore 235
ID - Indonesia 167
GB - Regno Unito 123
PL - Polonia 112
FI - Finlandia 110
RU - Federazione Russa 102
IN - India 87
TR - Turchia 65
ES - Italia 31
AU - Australia 28
BE - Belgio 26
CZ - Repubblica Ceca 24
IR - Iran 23
CI - Costa d'Avorio 22
AR - Argentina 18
CA - Canada 18
HK - Hong Kong 18
JP - Giappone 17
MX - Messico 17
NL - Olanda 16
BR - Brasile 14
ET - Etiopia 14
KR - Corea 13
CH - Svizzera 12
CO - Colombia 10
AT - Austria 9
PH - Filippine 7
EG - Egitto 6
MK - Macedonia 6
CL - Cile 5
GR - Grecia 5
PE - Perù 5
TW - Taiwan 5
ZA - Sudafrica 5
GH - Ghana 4
IL - Israele 4
NO - Norvegia 4
RO - Romania 4
VN - Vietnam 4
DK - Danimarca 3
IQ - Iraq 3
MT - Malta 3
PK - Pakistan 3
PT - Portogallo 3
BJ - Benin 2
KW - Kuwait 2
LT - Lituania 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BO - Bolivia 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 9.236
Salva come PNG Salva come JPEG
Città #
Chandler 658
Ashburn 467
Dublin 275
Jacksonville 255
San Mateo 225
Jakarta 165
Wilmington 163
Nanjing 151
Singapore 147
Woodbridge 120
Ann Arbor 106
Warsaw 105
Houston 93
Lawrence 92
Cattolica 88
Rome 81
Boston 80
Milan 75
Dearborn 71
Fairfield 70
Beijing 69
Moscow 65
New York 62
Nürnberg 59
Redwood City 59
Princeton 53
Seattle 52
Los Angeles 48
Izmir 46
Chicago 40
Nanchang 38
Mountain View 32
Shenyang 32
Tianjin 29
University Park 26
Redmond 25
Boardman 24
Hebei 24
Bremen 23
Hangzhou 23
Zhengzhou 23
Abidjan 22
Brno 22
Kunming 22
Pune 20
Detroit 19
Brussels 18
Shanghai 18
Bareggio 17
Cambridge 17
Federal 16
Hounslow 16
Mexico 16
Tobarra 16
Wayne 16
Busto Arsizio 15
Fremont 15
Leawood 15
Marseille 15
Augusta 14
Norwalk 14
Washington 13
Hong Kong 12
Jiaxing 12
Lancaster 10
Munich 10
Simi Valley 10
Andover 9
Changsha 9
Falls Church 9
Lanzhou 8
Bursa 7
Edinburgh 7
Guangzhou 7
Helsinki 7
Quezon City 7
Vienna 7
Ardabil 6
Florence 6
Hefei 6
Kish 6
Kraków 6
Latham 6
London 6
Padova 6
Prilep 6
Araucária 5
Bogotá 5
Catania 5
Chieti 5
Gurgaon 5
Indiana 5
Nuremberg 5
Toronto 5
Verona 5
Accra 4
Atlanta 4
Bern 4
Cape Town 4
Central 4
Totale 4.945
Salva come PNG Salva come JPEG
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 266
More, more, more: Reducing thrombosis in acute coronary syndromes beyond dual antiplatelet therapy-current data and future directions 250
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 229
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Metabolic Syndrome: systematic review and meta-analysis 155
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. 141
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 138
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 132
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study 121
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 119
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 116
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 113
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 113
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 107
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 105
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 105
Effect of fibrinogen concentration on the velocity of platelet aggregation. 104
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 102
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 101
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 100
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 98
Increased thromboxane biosynthesis in essential thrombocythemia. 87
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 87
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 85
Drug insight: aspirin resistance- fact or fashion 84
Aspirin, stroke and drug-drug interactions 83
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 83
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis 81
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 80
Fechtner syndrome: report of a third family and literature review 79
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 78
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. 78
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 77
Type 2 Diabetes, Obesity, and Aspirin Responsiveness* 76
Aspirin: promise and resistance in the new millennium. 74
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 74
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia 74
The future of antiplatelet therapy in cardiovascular disease 72
Farmaci antipiastinici 72
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 71
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 69
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment 67
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 67
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 65
Another family with IGPS 65
Identifying determinants of variability to tailor aspirin therapy 65
Platelet progenitors: the hidden drug target 65
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 64
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 64
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 63
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 62
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 62
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 62
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 61
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 61
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 60
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 60
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 59
Eicosanoid biosynthesis and metabolism in myeloproliferative disorders 58
Familial autoimmune myasthenia gravis with different pathogenetic antibodies 58
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 57
Determinants of the interindividual variability in response to antiplatelet drugs. 57
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 57
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 57
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. 56
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 56
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease 56
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 55
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation 55
Increased thromboxane metabolites excretion in liver cirrhosis. 54
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 54
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 54
Nonsteroidal antiinflammatory drugs: past, present and future 53
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 51
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. 51
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 51
Antithrombotic therapy in diabetes: which, when, and for how long? 51
Autosomal dominant giant platelet syndrome: a hint of the same genetic defect as in Fetchner syndrome owing to a similar genetic linkage to chromosome 22q11-13 50
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. 50
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 50
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 50
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 50
Unmet clinical needs of antithrombotic treatment in Philadelphia negative myeloproliferative neoplasms 49
Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs? 49
Interindividual Variability in response to aspirin and P2Y12 blockers in patients at high cardiovascular risk-the state of the evidence 48
Aspirin and Other COX-1 Inhibitors 48
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 47
Role of prostacyclin in the cardiovascular response to thromboxane A2 47
The lifespan determinant p66sch drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 47
Pathophysiology of Thrombosis in Peripheral Artery Disease 47
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 47
Farmaci Antipiastrinici 46
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 46
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 44
Effect of ketorolac, ketoprofen and nefopam on platelet function 44
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation 44
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 44
LACK OF AN ASSOCIATION BETWEEN INHERITED THROMBOPHILIC RISK FACTORS AND IDIOPATIC SUDDEN SENSORINEURAL HEARING LOSS IN ITALIAN PATIENTS 44
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness 43
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 43
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 43
Totale 7.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020798 0 0 0 134 61 84 97 41 51 74 138 118
2020/20211.038 43 113 24 108 149 54 115 27 140 50 181 34
2021/20221.145 157 93 13 73 86 32 32 187 44 33 175 220
2022/20232.133 313 301 176 241 175 237 75 172 257 43 95 48
2023/20241.357 43 348 42 179 80 132 97 29 28 69 136 174
2024/2025361 61 54 196 50 0 0 0 0 0 0 0 0
Totale 9.388